Medication info
Pregabalin 75 mg Capsule

Pregabalin 75 mg Capsule

Prescription medicationHard capsule경구
Ingredient · strength
Pregabalin›75mg / 1 capsule
Manufacturer / importer
(유)한풍제약
Appearance
A hard capsule with a reddish-brown upper part and a white lower part containing white powder
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 201905662 · Approved 2019.08.12 · Insurance code 658107070

Summary

Main use
Treatment of peripheral and central neuropathic pain, adjunctive effect for partial seizures in epilepsy, improvement of fibromyalgia
Who takes it
Adults · Children
Adult dose
This medication is administered orally as pregabalin, with a total daily dose divided into 2 doses regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dosage is 150 mg daily, which may be increased to 300 mg daily after 3 to 7 days. If necessary, it can be further increased to a maximum of 600 mg daily at 7-day intervals. - Central neuropathic pain: Starting dosage is 150 mg daily, with potential increment to 300 mg daily after one week.
Child dose
There is insufficient safety and efficacy data in children under 12 years of age and adolescents aged 12 to 17, thus administration is not recommended.

Ingredients

Manufacturer
(유)한풍제약

Efficacy & effects

Treatment of peripheral and central neuropathic pain, adjunctive effect for partial seizures in epilepsy, improvement of fibromyalgia

  • Peripheral neuropathic pain
  • central neuropathic pain
  • partial seizures
  • fibromyalgia
View approved original text

This medication is used to treat peripheral and central neuropathic pain in adults. Additionally, it is utilized as an adjunctive treatment for partial seizures in patients with epilepsy, helping to alleviate symptoms. It is also effective in relieving symptoms in patients with fibromyalgia. This drug aids in managing pain and seizures related to various neurological disorders, thereby enhancing the quality of life for patients.

How to take

Adult dose

This medication is administered orally as pregabalin, with a total daily dose divided into 2 doses regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dosage is 150 mg daily, which may be increased to 300 mg daily after 3 to 7 days. If necessary, it can be further increased to a maximum of 600 mg daily at 7-day intervals. - Central neuropathic pain: Starting dosage is 150 mg daily, with potential increment to 300 mg daily after one week.

Child dose

There is insufficient safety and efficacy data in children under 12 years of age and adolescents aged 12 to 17, thus administration is not recommended.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or abnormal mood changes occur during use, patients must inform their healthcare provider immediately. Patients with hypersensitivity to any ingredient in this medication or lactose intolerance should not use it, and lactose-containing formulations should not be administered to patients with hereditary lactose metabolism disorders. Diabetic patients should be cautious, as weight gain may necessitate dosage adjustments for blood glucose control medications. If symptoms of angioedema, such as swelling of the face or around the mouth, occur, stop taking the medication immediately. Elderly patients could experience dizziness, drowsiness, or confusion when taking this medication, and care should be taken to ensure safety until they acclimate to these effects. Vision disturbances or changes may occur, and discontinuing the medication could lead to improvement in these symptoms. Withdrawal symptoms such as insomnia, headache, nausea, and anxiety may occur when discontinuing the medication, so consultation with a healthcare provider is necessary. Patients with a history of drug abuse should be particularly cautious, as this medication may carry a high risk of abuse, and monitoring for signs of abuse is advised. Patients with impaired kidney function may require dosage adjustments, and there have been cases of improved kidney function following cessation of treatment. Patients with heart disease should exercise caution when taking this medication, especially those with severe congestive heart failure. Caution should also be observed when taken with opioid analgesics, as there is an increased risk of central nervous system depression, which can lead to serious side effects, such as respiratory suppression. Pregnant women should avoid taking this medication during early pregnancy due to the risk of congenital abnormalities in the fetus, and women of childbearing age should use effective contraception. Lactating women should either avoid breastfeeding while taking this medication or consult with their healthcare provider, as this drug can be passed into breast milk and affect the infant. Caution should be exercised while driving or operating machinery, as this medication may cause dizziness or drowsiness. Overdose of this medication may lead to symptoms such as drowsiness, confusion, and depression, necessitating immediate medical attention, and treatment such as hemodialysis may be required. Keep this medication out of reach of children and avoid transferring it to other containers. If severe rash or allergic reaction occurs, discontinue use immediately and seek medical evaluation.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, painful mucous membranes in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), profound fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

  • Dizziness
  • drowsiness
  • confusion
  • disorientation
  • irritability
  • depression
  • euphoria
  • decreased libido
  • insomnia
  • depersonalization
Show 21 more
  • hyperesthesia
  • restlessness
  • anxiety
  • mood swings
  • emotional lability
  • hallucinations
  • abnormal dreams
  • increased libido
  • panic attacks
  • loss of impulse control
  • apathy
  • ataxia
  • coordination disorders
  • balance disturbances
  • memory loss
  • attentional deficits
  • cognitive impairment
  • tremors
  • speech disorders
  • sensory disturbances
  • sensory loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that prevents exposure to air and moisture, at room temperature between 15 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing white powder

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.